HLA stands for human leukocyte antigen. HLA typing is utilized in order to match patients and donors for bone marrow or cord blood transplants. Human leukocyte antigens referred to proteins that can be inherited from the parents. In order to know the location of the cells inside the body and recognize which cells didn’t belong to the body and which HLA markers are used in the immune system.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742

HLA Typing for Transplant Market

[193 Pages Report] The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantation; increased funding, research grants, and public-private investments; technological shift from serological assays to gene-based HLA profiling; and improving healthcare infrastructure across developing countries.

Factors such as growing number of solid organ, soft tissue, and stem cell transplantations; technological advancements; and increased funding, research grants, and public-private investments are the key market drivers for the HLA-based transplant diagnostics industry. However, high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedure restrain the growth of the market to a certain extent.

Based on the product, the reagents & consumables segment held the largest share of the market in 2019.

Based on the product, the HLA typing for the transplants market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of the global HLA typing for the transplants market in 2019. Factors such as the increasing patient emphasis on effective and early patient profiling during organ transplantation and the growing adoption of transplant diagnostic techniques (includes HLA typing) in related research studies are driving the growth of this segment.

Major Growth Boosters : The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the growing number of transplant procedures, and technological advancements in the field of transplant diagnostics: View TOC : https://www.marketsandmarkets.com/Market-Reports/transplant-diagnostics-market-96374742.html

Based on technology, the molecular assays segment is expected to witness the highest growth during the forecast period.

Based on technology, the HLA typing for the transplants market is segmented into molecular assay and non-molecular assay technology. The molecular assay technology segment is expected to register the highest CAGR during the forecast period. Factors such as its varied applications in patient profiling, rising public-private investments to support product development, and increasing clinical evidence of its efficacy are driving the growth of this segment.

Based on the application, the diagnostic application segment accounted for the largest share of this market in 2019.

Based on the application, the HLA typing for the transplants market is categorized into diagnostic and research applications. Diagnostic applications accounted for the largest share of the HLA typing for the transplants market in 2019. Increasing adoption of molecular assay procedures for pathogen detection & histocompatibility testing, and the rising incidence of chronic diseases, and supportive government regulations to increase organ donations across major healthcare markets are the key factors supporting the growth of this application segment

North America accounted for the largest share of the HLA typing for transplants market in 2019

North America accounted for the largest share of the HLA typing for the transplants market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products (includes HLA typing) coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers & their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.

Key Questions Addressed by the Report:

What are the growth opportunities related to the adoption of HLA typing for transplant products across significant regions in the future?
Emerging countries show immense opportunities for the growth and adoption of HLA typing for transplant instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?
Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
What are the newest trends and advancements in the HLA typing for the transplants market?
Request Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742

About MarketsandMarkets

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth emerging opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain-points around revenues decisions.